CANbridge Pharmaceuticals Inc 2025 Sustainability Report
Company: CANbridge Pharmaceuticals Inc
Sector: Manufacturing
Country: China
Year: 2025
Type: Sustainability Report
Pages: 53
The report expands its climate disclosure by identifying material Scope 3 categories for the first time, while noting that environmental data primarily reflects Chinese Mainland operations after office and laboratory changes. It reports 62 employees and no work-related fatalities during the reporting period. Community investment included approximately RMB35,058,000 in donations, mainly supporting rare-disease patient assistance, healthcare research and related welfare initiatives.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.